Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients. [electronic resource]
Producer: 20100914Description: 2354-9 p. digitalISSN:- 1098-6596
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- administration & dosage
- Bacterial Infections -- drug therapy
- Bayes Theorem
- Carbapenems -- administration & dosage
- Creatinine -- metabolism
- Critical Illness
- Cross Infection -- drug therapy
- Doripenem
- Female
- Humans
- Kidney -- metabolism
- Male
- Metabolic Clearance Rate
- Middle Aged
- Models, Biological
- Nonlinear Dynamics
- Pneumonia, Bacterial -- drug therapy
- Pyelonephritis -- drug therapy
- Renal Insufficiency -- metabolism
- Urinary Tract Infections -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.